Exercise Intensity, Duration Can Affect CKD Risk in Obesity, Type 2 Diabetes

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 7, 2024 -- For adults with overweight/obesity and type 2 diabetes (T2D), longer duration of moderate-to-vigorous physical activity (MVPA) and increases in MVPA are associated with a reduced risk for progression to chronic kidney disease (CKD), according to a study published online Feb. 6 in the British Journal of Sports Medicine.

Mengyi Liu, from Nanfang Hospital in Guangzhou, China, and colleagues examined the long-term association of objectively measured MVPA and its longitudinal changes with progression to CKD in patients with T2D and overweight/obesity in a study including 1,746 participants. MVPA was measured at baseline and years 1, 4, and 8.

In total, 567 participants experienced progression to CKD during a median follow-up of 12.0 years. The researchers observed a linear inverse association of cumulative average total MVPA and MVPA accumulated in bouts of ≥10 minutes with progression to CKD (per 100 minutes/week higher amount: hazard ratios, 0.91 and 0.81, respectively). From baseline to year 4, an increase in total MVPA (fourth quartile; ≥63.2 minutes/week) was associated with a reduced risk for progression to CKD compared with the largest reduction in MVPA (<−198.3 minutes/week; hazard ratio, 0.67).

"Our study has important public health implications because it suggests that maintaining a high level of MVPA, regardless of length of the bout, may have renal benefit for adults with overweight/obesity and T2D, especially for individuals who are unwilling or unable to engage in PA bouts that are ≥10min in duration," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-08 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords